Search results
He is the principal author on several scientific and clinical research papers including high impact publications in Cancer Cell, Nature Biotechnology and Lancet Oncology. He has been awarded a number of national and international research grants.
Jan 31, 2022 · Australian biotechnology company EnGeneIC has cancer and COVID-19 squarely in its sights. Armed with world-first cyto-immunotherapy, Co-Founders and Joint CEOs Jennifer MacDiarmid and Himanshu Brahmbhatt believe effective treatment may be closer than ever.
Himanshu Brahmbhatt. Co-Founder, Joint-CEO & Director. View in org chart. Himanshu graduated with an M.Sc. from the MS University (Baroda, India) and Ph.D from University of Adelaide (Australia).
Oct 2, 2011 · Four years ago, Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt sparked worldwide interest with a revolutionary new technique to deliver chemotherapy. Animal tests have produced spectacular results and now the scientists are ready to move onto human trials. Transcript.
Armed with world-first cyto-immunotherapy, Co-Founders and Joint CEOs Jennifer MacDiarmid and Himanshu Brahmbhatt believe effective treatment may be closer than ever. The battle against cancer has brought out the best in the biopharmaceutical industry.
View Himanshu Brahmbhatt’s profile on LinkedIn, a professional community of 1 billion members. Experience: EnGeneIC Cancer Therapeutics · Location: Greater Sydney Area · 500+ connections on...
Himanshu Brahmbhatt is known for Rog (2005), Vishwasghaat (1996) and Dil Hai Ki Manta Nahin (1991).
